BNP/PUT/FRESENIUS MEDICAL CARE/30/0.1/20.12.24 Share Price

Warrant

DE000PE801P7

Delayed Deutsche Boerse AG 05:51:09 26/06/2024 pm IST
0.11 EUR 0.00% Intraday chart for BNP/PUT/FRESENIUS MEDICAL CARE/30/0.1/20.12.24
1 month+26.44%
3 months-54.17%
Date Price Change
26/24/26 0.11 0.00%
25/24/25 0.11 0.00%
24/24/24 0.11 -8.33%
21/24/21 0.12 +9.09%
20/24/20 0.11 -8.33%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 05:51 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE801P
ISINDE000PE801P7
Date issued 13/02/2023
Strike 30
Maturity 20/12/2024 (177 Days)
Parity 10 : 1
Emission price 0.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.42
Lowest since issue 0.066
Spread 0.01
Spread %8.33%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.67 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.07%
Consensus